alpha-thrombin upregulates G alpha(i3) in human vascular endothelial cells

被引:9
作者
Shreeve, SM [1 ]
Shatos, MA [1 ]
Thorin, E [1 ]
机构
[1] UNIV VERMONT,DEPT BIOCHEM,BURLINGTON,VT 05405
关键词
endothelium; obesity; G-proteins; thrombin;
D O I
10.1161/01.STR.27.12.2211
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose During thrombosis, alpha-thrombin becomes sequestered by fibrin and the subendothelial basement membrane, and it is available to interact with the vasculature over prolonged periods. in this study, we investigated the long-term effect of alpha-thrombin on G(alpha i3) and G(alpha s) levels in human vascular endothelial cells (EC). Because obesity is associated with changes in receptor signaling in many animal models, we also explored the influence of this clinical risk factor. Methods Primary cultures of human EC were exposed to alpha-thrombin for 16 hours, and immunologically detectable G(alpha i3) and G(alpha s) levels were measured. Results alpha-Thrombin (100 nmol/L) increased G(alpha i3) levels in EC derived from the cerebral microvasculature and superficial temporal artery (4.2 +/- 1.2-fold and 2.8 +/- 0.32-fold, respectively) but had no significant effect on EC derived from omental artery (P>.6) or from the superficial temporal artery of obese (body mass index >28 kg/m(2)) patients (P>.4). The expression of G(alpha s) was unchanged in all cell types (P greater than or equal to.1). Two other circulating peptides, vasoactive intestinal peptide and endothelin-1, failed to alter the expression of either G protein in EC from the cerebral microvasculature, further demonstrating the specificity of the alpha-thrombin effect. However, thrombin receptor activating protein-14 mimicked the alpha-thrombin response and increased G(alpha i3) in EC derived from the cerebral microvasculature and superficial temporal artery. Conclusions We conclude that alpha-thrombin increases G(alpha i3) expression in some EC through activation of its tethered liganded receptor. Obesity appears to suppress this action of alpha-thrombin.
引用
收藏
页码:2211 / 2215
页数:5
相关论文
共 48 条
[1]   THROMBIN IMMOBILIZED TO EXTRACELLULAR-MATRIX IS A POTENT MITOGEN FOR VASCULAR SMOOTH-MUSCLE CELLS - NONENZYMATIC MODE OF ACTION [J].
BARSHAVIT, R ;
BENEZRA, M ;
ELDOR, A ;
HYAM, E ;
FENTON, JW ;
WILNER, GD ;
VLODAVSKY, I .
CELL REGULATION, 1990, 1 (06) :453-463
[2]   BINDING OF THROMBIN TO SUBENDOTHELIAL EXTRACELLULAR-MATRIX - PROTECTION AND EXPRESSION OF FUNCTIONAL-PROPERTIES [J].
BARSHAVIT, R ;
ELDOR, A ;
VLODAVSKY, I .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1096-1104
[3]   LIVER BETA-ADRENERGIC RECEPTORS, G-PROTEINS, AND ADENYLYL-CYCLASE ACTIVITY IN OBESITY-DIABETES SYNDROMES [J].
BEGINHEICK, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :C1664-C1672
[4]   FLUOROMETRIC ASSAY OF PROTEINS IN NANOGRAM RANGE [J].
BOHLEN, P ;
STEIN, S ;
DAIRMAN, W ;
UDENFRIEND, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1973, 155 (01) :213-220
[5]  
BRASS LF, 1993, THROMB HAEMOSTASIS, V70, P217
[6]   MEDICAL PROGRESS - PRIMARY PREVENTION OF STROKE [J].
BRONNER, LL ;
KANTER, DS ;
MANSON, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (21) :1392-1400
[7]  
COUGHLIN SR, 1994, SEMIN HEMATOL, V31, P270
[8]   THE THROMBIN RECEPTOR [J].
DENNINGTON, PM ;
BERNDT, MC .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (05) :349-358
[9]  
Diehl NL, 1996, MOL PHARMACOL, V50, P624
[10]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743